DEFA14A: Acrivon Therapeutics Sets Date for Annual Stockholders Meeting
Proxy Statement
Acrivon Therapeutics announces its annual stockholders meeting to be held virtually on June 13, 2025, focusing on director elections and auditor ratification.
Summary
- Acrivon Therapeutics, Inc. will hold its annual meeting of stockholders on Friday, June 13, 2025, at 11:00 am Eastern Time.
- The meeting will be held virtually via the internet.
- Stockholders of record as of April 21, 2025, are eligible to vote.
- The agenda includes the election of Class III directors: Peter Blume-Jensen, M.D., Ph.D., Derek DiRocco, Ph.D., and Santhosh Palani, Ph.D., C.F.A.
- Stockholders will also vote to ratify the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Proxy materials are available online, and stockholders can request paper copies by June 3, 2025.
Sentiment
Score: 7
Explanation: The document is a standard corporate announcement, indicating a neutral to slightly positive sentiment due to the routine nature of the information.
Positives
- The virtual format of the meeting allows for broader accessibility for stockholders.
- Stockholders have the option to request paper or email copies of the proxy materials, ensuring they have access to the information they need to vote.
Future Outlook
The document outlines the procedural steps for the upcoming annual meeting, focusing on governance matters such as director elections and auditor ratification, which are standard components of corporate operations.
Industry Context
This announcement is a routine part of corporate governance, ensuring that stockholders have the opportunity to participate in key decisions regarding the company's direction and oversight.
Stakeholder Impact
- Shareholders are directly impacted through their voting rights on director elections and auditor ratification.
- The outcome of the meeting will influence the company's governance structure and financial oversight.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will proceed with the annual meeting on June 13, 2025.
Key Dates
| Date | Description |
|---|---|
| April 21, 2025 | Record date for stockholders eligible to vote at the annual meeting. |
| June 3, 2025 | Deadline to request paper copies of proxy materials. |
| June 13, 2025 | Date of the annual stockholders meeting. |
| December 31, 2025 | End of the fiscal year for which PricewaterhouseCoopers LLP is being considered as the independent auditor. |
Keywords
Annual Meeting, Stockholders, Proxy Statement, Acrivon Therapeutics, Director Election, Auditor Ratification, Virtual Meeting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.